A generic version of Breo Ellipta has been approved by the FDA, but the situation is complicated. While authorized generic versions exist on paper, they do not appear to be widely available in U.S. pharmacies yet. The brand-name version typically costs around $400 for a 30-day supply without insurance, so the generic question matters a lot financially.
What the FDA Has Approved
The FDA has approved authorized generic versions of Breo Ellipta, which contains two active ingredients: fluticasone furoate (a corticosteroid that reduces airway inflammation) and vilanterol (a long-acting bronchodilator that relaxes the muscles around your airways). The brand comes in two strengths: 100/25 mcg and 200/25 mcg, both delivered as a dry powder you inhale once daily.
However, “approved” and “available at your pharmacy” are two different things. As of now, these authorized generics do not appear to be commercially stocked, and pricing information for them hasn’t been established. Market launch delays are common with inhaler generics because the delivery device itself is complex to replicate. Patents covering both the drug formulation and the Ellipta inhaler device extend through October 2030, which creates a significant barrier for independent generic manufacturers looking to bring competing products to market.
Why Inhaler Generics Are Different
Generic inhalers face hurdles that generic pills don’t. With a tablet, a manufacturer just needs to prove the same active ingredient is absorbed into your bloodstream at the same rate. With an inhaler, the device design, particle size, and delivery mechanism all affect how much medication reaches your lungs. The Ellipta device is patented separately from the drug itself, which is why fully independent generics (ones made by companies other than the original manufacturer) haven’t reached the market.
An authorized generic is essentially the same product made by or for the original manufacturer, repackaged without the brand name. It uses the identical device and formulation. No independent, AB-rated generic exists for Breo Ellipta in the FDA’s Orange Book, meaning pharmacists cannot automatically substitute a different manufacturer’s version the way they can with most generic medications.
What It Costs Right Now
The average retail price for Breo Ellipta runs about $407 for a 30-day supply. Using discount coupons from services like GoodRx, you can find the generic version (listed as fluticasone furoate/vilanterol) for roughly $225 at some pharmacies, a savings of about 45%. That price fluctuates by pharmacy and location, so it’s worth checking multiple options.
Your actual out-of-pocket cost depends heavily on your insurance plan. Many commercial insurance plans cover Breo Ellipta but may place it on a higher formulary tier, meaning larger copays. Some plans prefer a competing combination inhaler instead, which could mean prior authorization paperwork from your prescriber before coverage kicks in.
Ways to Lower Your Cost
If you’re paying a significant amount out of pocket, a few options are worth exploring. GlaxoSmithKline, the manufacturer, has historically offered copay cards and patient assistance programs for eligible patients. Eligibility requirements vary, and these programs typically apply to the brand-name product rather than generics.
Pharmacy discount programs through GoodRx, RxSaver, or similar tools can cut the price substantially even without insurance. Prices vary between pharmacies by $100 or more for the same product, so comparing is worthwhile. Some large retailers and mail-order pharmacies also negotiate lower prices on specialty inhalers.
If cost is a persistent barrier, ask your prescriber whether a therapeutic alternative might work for your condition. Several other combination inhalers treat asthma and COPD with similar drug classes, and some have generics that are more widely available and less expensive. Switching inhalers isn’t always straightforward since each device works slightly differently, but it’s a conversation worth having.
COPD vs. Asthma: Different Strengths Apply
Breo Ellipta 100/25 is the only strength approved for COPD and is taken as one inhalation per day. For asthma, both the 100/25 and 200/25 strengths are options, with the higher dose reserved for people who need more inflammation control. The maximum dose is one inhalation of the 200/25 strength daily. If you’re looking for a generic, confirm which strength you need since availability and pricing can differ between the two.